Login

Dapagliflozin vermindert das Risiko für Krankenhausaufenthalte von Typ-2-Diabetes-Patienten

Dapagliflozin
DOI: 10.1007/s11428-023-01060-1 Publication Date: 2023-06-13T08:02:14Z
Abstract Supplemental Material References Cited by
AUTHORS (1)
Imke Schamarek
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (8)
CITATIONS (0)
EXTERNAL LINKS
OPENAIRE - Products  CROSSREF - Publications  OPENALEX - Publications 
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....